These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8325345)

  • 1. Presentation of mouse tum- P91A antigen from chimeric proteins with different subcellular localizations by class I molecules of the major histocompatibility complex.
    Godelaine D; Van Pel A; Van Malderen M; Beaufay H
    Eur J Immunol; 1993 Jul; 23(7):1731-4. PubMed ID: 8325345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tum- antigens P91A and P198 derive from proteins located in the cytosolic compartment of cells.
    Verlant V; Amar-Costesec A; Godelaine D; Turu C; Van Pel A; De Plaen E; Dautry-Varsat A; Beaufay H
    Eur J Immunol; 1993 Jul; 23(7):1727-30. PubMed ID: 8325344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation.
    Lammert E; Arnold D; Rammensee HG; Schild H
    Eur J Immunol; 1996 Apr; 26(4):875-9. PubMed ID: 8625982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Q7 alpha 3 domain alters T cell recognition of class I antigens.
    Aldrich CJ; Lowen LC; Mann D; Nishimura M; Hood L; Stroynowski I; Forman J
    J Immunol; 1991 May; 146(9):3082-90. PubMed ID: 1849941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of hen egg lysozyme-specific and major histocompatibility complex class I-restricted cytolytic T lymphocytes: recognition of cytosolic and secreted antigen expressed by transfected cells.
    Forquet F; Calin V; Trescol-Biemont MC; Kanellopoulos J; Mottez E; Kourilsky P; Rabourdin-Combe C; Gerlier D
    Eur J Immunol; 1990 Oct; 20(10):2325-32. PubMed ID: 2242761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex and T cell receptor interaction of the P91A tum- peptide.
    McCormick D; Stauss HJ; Thorpe C; Travers P; Dyson PJ
    Eur J Immunol; 1996 Dec; 26(12):2895-902. PubMed ID: 8977283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal domains: functional T cell recognition requires preservation of fine structural determinants.
    McCluskey J; Boyd L; Foo M; Forman J; Margulies DH; Bluestone JA
    J Immunol; 1986 Dec; 137(12):3881-90. PubMed ID: 2431046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
    Buckner FS; Wipke BT; Van Voorhis WC
    Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.
    Solheim JC; Alexander-Miller MA; Martinko JM; Connolly JM
    J Immunol; 1993 Feb; 150(3):800-11. PubMed ID: 8380825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.
    De Plaen E; Lurquin C; Van Pel A; Mariamé B; Szikora JP; Wölfel T; Sibille C; Chomez P; Boon T
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2274-8. PubMed ID: 3127830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
    Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
    Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell tolerance and activation to a transgene-encoded tumor antigen.
    Antoniou A; McCormick D; Scott D; Yeoman H; Chandler P; Mellor A; Dyson J
    Eur J Immunol; 1996 May; 26(5):1094-102. PubMed ID: 8647173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells.
    Bellone M; Iezzi G; Manfredi AA; Protti MP; Dellabona P; Casorati G; Rugarli C
    Eur J Immunol; 1994 Nov; 24(11):2691-8. PubMed ID: 7525300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genes encoding T cell defined tum- antigens.
    Van Pel A; De Plaen E; Lurquin C; Van den Eynde B; Lethé B; Hainaut P; Lemoine C; Boon T
    Princess Takamatsu Symp; 1988; 19():255-63. PubMed ID: 3151988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.